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Abstract 
Premature infants are at high risk of neonatal brain injury due to poor cerebrovascular 
regulation, leading to periods of dangerously low cerebral blood flow (CBF) and possible 
injury. However, there are currently no established bedside methods of monitoring CBF to 
alert the intensive care staff to cerebrovascular dysfunction. Diffuse correlation spectroscopy 
(DCS) is an emerging noninvasive optical technique for monitoring relative CBF. I developed 
a stand-alone DCS method of monitoring absolute CBF by incorporating a quantitative 
dynamic contrast-enhanced (DCE) technique. This required modifying a DCS system to 
capture multi-distance data to measure the tissue optical properties and to perform DCE 
experiments. The feasibility of the technique was assessed by measuring CBF in piglets under 
three flow conditions. For validation, the tissue optical properties were compared to 
measurements from time-resolved near-infrared spectroscopy (NIRS). Across 7 animals, a 
strong linear correlation was observed between CBF values derived using the two sets of 
optical properties at baseline (R2=0.95), hypercapnia (R2=0.83) and hypocapnia (R2=0.88). 
These results demonstrate that the developed DCS system provided the unique ability to 
provide real-time monitoring of absolute CBF.  
Keywords 
Diffuse correlation spectroscopy, NIRS, Optical diagnostics, medical imaging, spatially 
resolved NIRS, bolus tracking, neuromonitoring, neonates. 
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Chapter 1  
1  Introduction 
This chapter provides an overview of biomedical optics as applied to brain monitoring in 
the neonatal intensive care unit and the limitations of current methods. The principles of 
near-infrared spectroscopy (NIRS) and the methodology employed to measure cerebral 
blood flow (CBF) are outlined. Lastly, diffuse correlation spectroscopy (DCS), which is 
the focus of my thesis is presented. 
1.1  Clinical Significance 
According to the Canadian Institutes of Health Research, of the 390,000 babies who are 
born in Canada each year, nearly 8% are preterm births (less than 37 weeks of gestation). 
Preterm birth is associated with two-third of infant deaths in Canada. In addition, preterm 
infants are at a higher risk of brain injury, with 40-50% developing long-term cognitive 
and behavioral deficits and 5-10% developing major disabilities such as cerebral palsy [1]. 
The major forms of preterm brain injury are associated with damage to the cerebral 
vasculature. One of the most common is intraventricular hemorrhage (IVH), which arises 
in one-third of very preterm infants [2][3]. It refers to internal bleeding from the germinal 
matrix into the ventricles and adjacent brain tissue. In more than 90% of the cases, IVH 
occurs within the first 3 postnatal days, and it is a major risk factor for death and poor 
neurodevelopmental outcome. Despite advances in neonatal care, it remains a significant 
problem. The other major form of neonatal brain injury is periventricular leukomalacia 
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(PVL), which refers to ischemic injury in the white matter near the lateral ventricles [4]. 
The vulnerability of the preterm brain to these types of injury is believed to be a 
combination of cerebrovascular risk factors coupled with systematic factors, particularly 
the high incidence of hypotension. Cerebral autoregulation (CA) refers to the ability to 
maintain normal CBF despite fluctuations in arterial blood pressure. It is known that CA is 
impaired in preterm brain due to the immaturity of the cerebral vessels [5][6]. In addition, 
CBF is extremely low in the preterm brain [7], and infants who developed brain injury have 
lower CBF [8]. It is likely that the combination of these two factors makes the preterm 
brain susceptible to brain injury; i.e., hemorrhage during periods of hypertension and 
ischemia when blood pressure decreases.   
The seminal study conducted by Soul et al. in 2007 used NIRS to show that cerebral 
pressure-passivity is common in the preterm brain [9]. This was performed by correlating 
changes in tissue oxygenation, used as an indirect marker of CBF, to fluctuations in arterial 
blood pressure. Their results demonstrated that 87 of the 90 preterm infants had periods of 
cerebral pressure-passivity; however, they did not find a correlation to brain injury. One 
possible explanation is that they only looked at relative CBF changes and were not able to 
define the true magnitude of changes in blood flow by monitoring tissue oxygenation. 
Therefore, to overcome the low predictive power of this technique and improve sensitivity, 
the ideal method should be able to quantify CBF in order to determine how low flow drops 
during pressure fluctuations. This would be analogous to assessing brain injury associated 
with ischemic stroke in adults since severity of injury depends on both the duration and 
value of ischemic flow[10].  
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1.2 Near Infrared Spectroscopy 
Near infrared spectroscopy is a non-invasive optical technique used primarily to monitor 
tissue oxygenation. It utilizes light in the near-infrared region (700-1000 nm), known as 
the optical window[11]. Due to low absorption in this band, light can penetrate deeper into 
tissue compared to visible light, which has a penetration depth of only a few millimeters. 
The interaction of light with tissue is by scattering and absorption. The latter refers to the 
transfer of energy to an absorbing molecule by excitation of a vibrational state. That is, if 
the frequency of a photon equals the energy that is required by the molecules to transition 
to a higher energy state, then the photon is absorbed, otherwise it is scattered (i.e., re-
emitted in another direction). Scattering and absorption are characterized by their 
respective exponential coefficients: s for scattering and a for absorption. These 
coefficients are the reciprocal of the distance a photon typically travels before it is either 
scattered or absorbed. In the NIR range, s is approximately 100 times greater than a, 
reflecting the low absorption and high scattering properties of tissue. 
The first person to arithmetically define absorption in a non-scattering medium was Pierre 
Bouguer. He discovered that in a homogeneous medium the decrease in light intensity is 
related exponentially to a and the distance between source and detector (ρ): 
 𝐼 = 𝐼𝑜𝑒
−𝜇𝑎𝜌 1-1 
where Io is the source light intensity and I is the measured light intensity. In 1852, August 
Beer observed that light absorption was proportional to the concentration (ci) of a 
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chromophore (light-absorbing molecule) in the medium. In the presence of multiple 
chromophores, the absorption coefficient can be written as: 
 𝜇𝑎(λ) = ln⁡(10)∑ 𝜖𝑖(λ)𝑐𝑖
𝑖
 1-2 
where ε is the wavelength-dependent extinction coefficient of the ith chromophore. Of all 
the chromophores in tissue, the main absorbing chromophores of NIR light are 
oxyhemoglobin, deoxyhemoglobin and water. Their wavelength-dependent absorption 
characteristics are illustrated in Figure 1-1. 
Figure 1-1 highlights that the dominant tissue chromophore in the NIR region is 
hemoglobin, and the optical window is defined by the increase in absorption of hemoglobin 
at shorter wavelengths and by water at longer wavelengths. In principle, the concentration 
Figure 1-1: Molar extinction coefficients for the three main endogenous 
chromophores: oxyhemoglobin (HbO2), deoxyhemoglobin (HHb) and 
water  
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of the main chromophores can be determined by applying Equation 1-2 to absorption data 
obtained at different wavelengths. However, the challenge to applying this approach to 
tissue is the much larger effects of light scattering. 
In tissue, scattering is forward directed; however, the photon direction quickly becomes 
isotropic. This occurs at  a distance given by ~1/s, where s is defined as the reduced 
scattering coefficient and is defined as: 
 μ𝑠
 (λ) = (1 − g(λ)). μ𝑠(λ) 1-3 
where g is the anisotropy factor, which is the average cosine of the scattering angle. It is a 
measure of the directionality of elastic scattering (i.e. scattering efficiency) and varies 
between -1 and 1. 
Since tissue is a highly scattering medium, due to the presence of many scattering particles 
and changes in refractive indices within a small volume (1 mm3), the number of scattering 
events is much higher than absorption interactions (µs >> µa). The main scattering 
constituents of a NIR photon, listed in order of scattering frequency, are lipoprotein 
membranes, mitochondria, red blood cells (RBCs), and other cellular components. These 
tissue scattering particles can be grouped into two categories: static and dynamic scatterers. 
The difference is the variation in phase of the interacting photon over time. Although 
scattering events occur more often with static tissue constituents, such as lipoprotein 
membranes and mitochondria, the phase change is time invariant, and the major 
contribution to the temporal phase fluctuations of a NIR photon is due to moving RBCs 
[12][13]. The variation in phase due to motion is an important phenomenon that can be 
exploited to measure flow. 
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1.3 Propagation of Light in Tissue 
In biological tissues, scattering processes play a substantial role in the propagation of light. 
These scattered radiations contain information about tissue structural elements, their 
orientation, optical properties, and other parameters. To extract information and interpret 
experimental results, appropriate optical models for tissue based on radiation propagation 
are required. 
1.3.1 Radiative Transfer Equation 
Typically, the propagation of an electromagnetic wave in a medium can be solved using 
Maxwell’s equations; however, in tissue the occurrence of many scattering events makes 
obtaining solutions to Maxwell’s equations intractable. Due to this, simplification and 
different assumptions are needed to explain light propagation in tissue. Thus, when using 
Maxwell’s equation, we approximate the solution by looking at light propagation as a 
stream of photons and by characterizing the individual photon pathlengths with radiative 
transport theory [14]. As radiance (the power of light emitted in a direction per unit solid 
angle [W/cm2/sr]) travels within tissue, the radiative transport equation (RTE) 
mathematically models energy conservation by describing the interactions between 
particles and radiation: 
 1
𝑣
𝜕
𝜕𝑡
𝐿(𝑟, 𝑡, Ω) + ?̂?⁡∇⁡𝐿(𝑟, 𝑡, Ω) + (𝜇𝑎 +⁡𝜇𝑠)𝐿(𝑟, 𝑡, Ω)
= ⁡𝜇𝑠∫ 𝐿(𝑟, 𝑡, Ω)𝑃(Ω, Ω՜) ∂
4𝜋
Ω՜+ S(𝑟, 𝑡, Ω) 
1-4 
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where L(r,t,Ω) is the radiance in a medium at position r, traveling in direction Ω, at time t. 
The scattering phase function, P(Ω, Ω՜), represents the probability of scattering into a 
direction Ω՜ from direction Ω. The speed of light in the medium is v, the source term is 
S(r,t,Ω), and dΩ՜is the solid angle around Ω. 
In an infinitesimal volume, the above equation accounts for the energy losses due to 
scattering and absorption, and energy gains because photon scattered into the volume and 
due to a light source. Even though this equation simplifies the Maxwell’s equation, it is 
still complex and does not have analytical solutions. Therefore, further approximations are 
needed to solve the radiative transfer equation. 
1.3.2 Diffusion Approximation  
The diffusion approximation (DA) is one of the most widely used approximations to the 
radiative transfer equation. It is valid for conditions where the scattering length (ls=1/μs) is 
small compared to the distance of propagation. The standard approach to the diffusion 
approximation is through the PN approximation, in which all angular dependent quantities 
(i.e. radiance, phase function, and light source) in a spherical Legendre series is truncated 
at the first order. The DA holds when the PN assumes that the scattering coefficient is larger 
than the absorption coefficient, the observation point is far from the boundary of the 
medium, light is unpolarized, and the timescale is sufficiently long.  
Thus, the photon fluence rate, which linearly combines the power of the photons incident 
on the sphere of cross-sectional area L [W/cm2] can be written as: 
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𝜑(𝑟, 𝑡) = ∫𝐿((𝑟, 𝑡, Ω) 𝑑Ω 
1-5 
and the photon flux, J(r,t), defined as the vector sum of the radiance emerging from an 
infinitesimal volume [W/cm2] is given by: 
 
𝐽(𝑟, 𝑡) = ∫Ω. 𝐿((𝑟, 𝑡, Ω) 𝑑Ω 
1-6 
The radiance from PN approximation can also be derived independent of direction and is 
given by: 
 
𝐿((𝑟, 𝑡, Ω) =
1
4𝜋
𝜑(𝑟, 𝑡) +
3
4𝜋
𝐽(𝑟, 𝑡)Ω 
1-7 
By combining the photon fluence with the radiative transfer equation and integrating over 
the solid angle, we get the continuity equation of the fluence rate: 
 1
𝑣
𝜕
𝜕𝑡
𝜑(𝑟, 𝑡) +⁡∇⁡𝐽(𝑟, 𝑡) + 𝜇𝑎(𝑟, 𝑡)𝜑(𝑟, 𝑡) = ⁡S(𝑟, 𝑡) 
1-8 
The relationship between fluence rate and flux rate can be defined by Fick’s law, which 
relates the diffusion of photons in a scattering medium by: 
 
𝐽(𝑟, 𝑡) = −
𝐷(𝑟, 𝑡)
𝑣
∇𝜑(𝑟, 𝑡) 
1-9 
D(r,t) is the photon diffusion coefficient and is defined as: 
 𝐷(𝑟, 𝑡) =
𝑣
3(𝜇′𝑠 + 𝜇𝑎)
 1-10 
Thus, in tissue the radiance of the RTE equation by photon fluence (φ(r,t)) can be described 
by the DA. It is derived by substituting Fick’s Law into the fluence continuity equation to 
get: 
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 (𝐷(𝑟, 𝑡)∇2 − 𝑣𝜇𝑎(𝑟, 𝑡) −⁡
𝜕
𝜕𝑡
)𝜑(𝑟, 𝑡) = −𝑣𝑆(𝑟, 𝑡) 1-11 
The above equation can be used to characterize the paths travelled by photons that 
undergoes isotropic scattering, and unlike the RTE, analytical solutions are known for 
specifics geometries. 
1.3.3 Modified Beer-Lambert Law  
Modified Beer-Lambert law (MBBL) is an empirical model that is widely used to analyze 
reflectance signal in NIRS applications. It uses continuous-wave diffuse optical intensity 
measurements to derive changes in tissue optical property. As compared to the Beer-
Lambert law, which only accounts for tissue absorption, the MBBL accounts for light 
scattering by using the mean pathlength travelled by the photons through the highly 
scattering medium as the best estimate for the actual photon pathlength. The Modified 
Beer-Lambert law is derived from the first order Taylor expansion of the sample optical 
density (OD): 
 
𝑂𝐷0 ≈⁡𝑂𝐷0 + (
𝜕𝑂𝐷0
𝜕𝜇𝑎
)∆𝜇𝑎 + (
𝜕𝑂𝐷0
𝜕𝜇𝑠′
)∆𝜇𝑠
′  
1-12 
where OD0 is the baseline optical density, defined as the negative logarithm of the ratio of 
transmitted to incident light intensity: 
 
𝑂𝐷 = − log [
𝐼𝑡
𝐼0
] = 𝜇0𝜌 
1-13 
where I0 is the incident light, It is the transmitted light, ρ is the sample length and OD is 
proportional to the sample absorption coefficient (µa). The partial derivatives are evaluated 
at baseline condition, i.e. µa = µa
0 and µs = µs0 and the differential changes in absorption 
and scattering are denoted by ∆µa ≡ µa(t) − µa0 and ∆µs ≡ µs (t)− µs0. 
10 
 
Based on these approximations, changes in optical density from baseline are given by: 
 
𝑂𝐷 = − log (
𝐼𝑡
𝐼0
) ≈ 〈𝐿〉 ∆𝜇𝑎(𝑡) + (
𝜇𝑎
0
𝜇𝑠
′0) 〈𝐿〉∆𝜇𝑠
′(𝑡) ≈ 〈𝐿〉∆𝜇𝑎(𝑡) 
1-14 
The differential pathlength (⟨L⟩) is the mean pathlength that diffusing photons travel within 
the medium from source to detector and is defined as: 
 
〈𝐿〉 ≡
𝜕𝑂𝐷0
𝜕𝜇𝑎
 
1-15 
Thus, using the above expansion, we can derive a Modified Beer-Lambert law for analysis 
of NIRS reflectance signal [15]. 
1.4 Near-Infrared Techniques 
In clinical applications, NIRS data are acquired in either transmission or reflectance mode. 
In the former, the NIR light source is placed on one side of the medium, and the detector 
on the other side. Light is shone through the sample and collected after being scattered and 
absorbed. In reflectance mode, the NIR source and detector are placed on the same surface 
of the sample (such as the skin for in situ applications) and reflected photons collected are 
due to the high number of scattering events within the turbid medium. The latter technique 
is more common in neurological studies since the size of the human head makes it 
infeasible to collect information in transmission mode. Various NIR methods have been 
developed for this purpose and are described below. 
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1.4.1 Continuous-Wave NIRS 
Continuous-wave (CW) NIRS is the simplest type of in vivo NIRS techniques, since it only 
measures the reduction in light intensity due to absorption and scattering in the medium. 
Generally, CW NIRS uses the modified Beer-Lambert Law to model light attenuation and 
changes in a can be derived assuming scattering properties of the medium remain constant. 
Quantification of the concentration of the various chromophores is difficult with this 
simple approach since the differential pathlength is unknown and must be either assumed 
or measured by another method. [16]. Nevertheless, acquired attenuation data at multiple 
wavelengths (such as using multiple light emitting diodes) or across the NIR spectrum 
(using a broadband light source) can be used to monitor changes in the concentration of 
chromophores [17]. 
1.4.2 Spatially Resolved NIRS 
Spatially resolved spectroscopy (SRS) is a CW method involving the acquisition of light 
intensity measurements at multiple source-detector distances [18][19]. For a semi-infinite 
homogeneous medium having a source defined as r = 0 and a detector placed at r = rsd, the 
detected light intensity, known as the diffuse reflectance, is defined by the DA: 
 
R𝑑 ⁡(r𝑠𝑑) =
𝑧0
2𝜋
𝑒𝑥𝑝 [−𝜇𝑒𝑓𝑓(𝑧0
2 + 𝑟𝑠𝑑
2 )
1
2]
𝑧0
2 + 𝑟𝑠𝑑
2 ⁡[𝜇𝑒𝑓𝑓 +
1
(𝑧0
2 + 𝑟𝑠𝑑
2 )
1
2
] 
1-16 
where z0 = 1/µsdescribes the depth at which the direction of the emitted light becomes 
isotropic (i.e. entered the diffusion regime), and µeff is the effective attenuation coefficient: 
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𝜇𝑒𝑓𝑓 ≡ √3𝜇𝑎(𝜇𝑎 + 𝜇′𝑠) = ⁡√3𝜇𝑎𝜇
′
𝑠 
1-17 
For a large source-detector distance (i.e. rsd >> z0), the solution simplifies to: 
 
ln[𝑟𝑠𝑑
2 R𝑑 ⁡(r𝑠𝑑)] = −𝜇𝑒𝑓𝑓𝑟𝑠𝑑
2 + ln (𝜇𝑒𝑓𝑓 +
1
𝑟𝑠𝑑
2 ) + 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡 
1-18 
When 𝑟𝑠𝑑 >> 𝜇𝑒𝑓𝑓 the second term becomes a constant and a linear relationship is obtained 
between rsd and ln[rsd
2Rd(rsd)], and the -µeff gives the slope of the equation: 
 
ln[𝑟𝑠𝑑
2 R𝑑 ⁡(r𝑠𝑑)] = −𝜇𝑒𝑓𝑓𝑟𝑠𝑑
2 + 𝑖𝑛𝑡𝑒𝑟𝑐𝑒𝑝𝑡 
1-19 
Thus, by plotting the intensities at different source-detector distance, we can get a direct 
estimate of 𝜇𝑒𝑓𝑓, which can be used to estimate µa assuming a known value of µs 
1.4.3 Time-Resolved NIRS 
Time-resolved (TR) NIRS uses lasers capable of emitting ultrashort pulses of light (of the 
order of picoseconds) and fast detectors capable of detecting the arrival of single reflected 
photons through the medium. A histogram of photon arrival times is generated, called the 
temporal point spread function (TPSF)[20][21]. It reflects the multiple different paths that 
photons take through the medium due to scattering. However, the measured TPSF is also 
influenced by the dispersion of light by the instrumentation. Therefore, the true distribution 
of the photon times of flight (called the DTOF) through the medium can only be obtained 
by removing the effects of the instrument response function (IRF) from the measured TPSF 
(Fig 1-2). Assuming the IRF is properly characterized, then the tissue optical properties 
13 
 
(s and a) can be determined by modelling the DTOF by analytical solutions to the 
diffusion approximation.  
 
1.4.4 Frequency Domain NIRS 
Frequency domain NIRS can be considered the frequency analog of TR NIRS. With this 
approach, the light source is modulated at a known frequency, typically in the radio 
frequency range, and a fast detector is used to measure the change in light intensity (both 
DC and AC) as well as the phase shift between the emitted and detected light. The 
absorption and scattering coefficients can be determined by applying the DA to the 
measured phase shift and modulation amplitude in the frequency domain [22]. The 
Figure 1-2: Measured IRF of the instrument and the measured dispersion of the 
photon arrival time after the light interrogates the tissue (TPSF) 
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capability to collect phase information is the key difference between CW and frequency 
domain methods. However, phase measurements are inherently noisy, and frequency 
domain approaches require calibration against a tissue-mimicking phantom with known 
optical properties.  
1.5 Dynamic Contrast-Enhanced NIRS to Measure CBF  
Cerebral blood flow can be measured by NIRS using dynamic contrast-enhanced (DCE) 
techniques that rely on injecting of an optical contrast agent into the systemic circulation. 
The contrast agent acts as a blood flow tracer, whose transport through the 
microvasculature is modeled by constructing a kinetic model and applying it to the time 
dependent measurements of tracer concentration. The relationship relating the tissue 
concentration of contrast agent to its arterial blood concentration is given by: 
 
𝐶𝑡(𝑡) = 𝐶𝐵𝐹 ∙ ∫ 𝐶𝑎(𝑡 − 𝑢). 𝑅(𝑢)𝑑𝑢
𝑡
0
 
1-20 
where Ct(t) is the dye concentration in tissue as a function of time (t) measured by NIRS, 
Ca(t) is the arterial blood concentration measured by a dye oximeter, and R(t) is the impulse 
residual function, which represents the fraction of tracer in the tissue at time t, after an 
idealized bolus injection at time t=0 of unit concentration. The function CBF·R(t) can be 
extracted from the tissue and arterial ICG concentration curves by deconvolution. The 
initial height is equal to CBF since by definition R(0) = 1. Although this method is 
quantitative, it only provides a single CBF measurement and is therefore not suitable for 
continuous monitoring [23]. 
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1.6 Diffuse Correlation Spectroscopy 
Diffuse correlation spectroscopy (DCS) is an emerging non-invasive optical technique for 
monitoring tissue blood flow, which is similar to conventional NIRS, but it has the 
advantage of providing a continuous signal that is directly related to the movement of 
scatterers in tissue. DCS works by measuring the temporal correlation of coherent NIR 
light, which is dominated by the movement of red blood cells. It is an extension of dynamic 
light scattering (DLS), which follows single scattering events and is only applicable to 
optically thin samples. DCS, on the other hand, is a multiple scattering technique, which 
applies the methodology of DLS to thick samples. Here, individual scattering events 
combine to result in a net phase shift, which causes a decline in phase correlation. Because 
the primary moving light scatterers in tissue are RBCs, the measured phase changes are 
directly related to blood flow. However, DCS does not directly measure phase shifts, rather 
it measures temporal intensity fluctuations of coherent light, which are characterized by 
generating an autocorrelation function. In essence, faster moving RBCs lead to a more 
rapid loss of phase coherence, which is characterized by a rapid decrease in an 
autocorrelation function (Fig 1.2) [24][25]. 
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Figure 1-3: A) Schematic of a multiple light scattering event inside a tissue, where light 
interact with the moving RBCs and is scattered, with the solid and dotted lines showing the 
path the light takes at time t and later after delay at t+. B) Shows the intensity fluctuations 
detected by the detectors. C) Schematic shows the phase decay calculated based on the 
speed of the moving scatterers. 
 
1.6.1 Intensity Autocorrelation and Correlation Diffusion Equation 
In a scattering medium, the normalized temporal autocorrelation function of an electric 
field (E(t)) is given by: 
 
𝑔1 =⁡
〈𝐸(𝑡) ∙ 𝐸∗(𝑡 + 𝜏)〉
〈|𝐸(𝑡)|2〉
 
1-21 
where, 
 𝐺1 =⁡ 〈𝐸(𝑡) ∙ 𝐸
∗(𝑡 + 𝜏)〉 1-22 
is the diffuse electric field autocorrelation function,  is the autocorrelation delay time and 
E(t+) is the electric field after a delay . In DCS, temporal intensity fluctuations are 
measured rather than g1. The normalized intensity autocorrelation function, given by: 
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𝑔2 =
〈𝐼(𝑡) ∙ 𝐼∗(𝑡 + 𝜏)〉
〈|𝐼(𝑡)|2〉
 
1-23 
where I(t) is the light intensity detected at the tissue surface at time t. This normalized 
intensity autocorrelation function is related to g1(t) through the Siegert relationship: 
 𝑔2 = 1 + 𝛽|𝑔1(𝑡)|
2 1-24 
where β is the coherence factor of the detection system, which depends on the detection 
optics and is inversely proportional to the number of detected light modes. 
Analogous to characterizing changes in light reflectance through a turbid medium, G1 can 
be modelled using the diffusion approximation [26] [27]: 
 (𝐷(𝑟, 𝑡)∇2 − 𝑣𝜇𝑎(𝑟, 𝑡) − 𝑘𝐷
2(𝜏))𝐺1(𝑟, 𝜏) = −𝑣𝑆(𝑟, 𝑡) 1-25 
where 
 𝑘𝐷
2(𝜏) = 3𝜇′𝑠𝜇𝑎 + 𝛼𝜇
′
𝑠
2𝑘0
2〈𝑟(𝜏)〉 1-26 
accounts for the loss of correlation due to the motion of scatterers. <r()> is the mean-
square displacement of the moving scatterers during a correlation time τ and is the 
proportion of moving scatters (largely RBCs in tissue), k0 = 2πn/λ is the wavenumber of 
light (λ is wavelength and n is the refractive index)[13]. In order to compute the g2(ρ,τ) to 
estimate blood flow, an appropriate analytical model capable of mapping the tissue 
geometry and the motion of the erythrocytes in the tissue is required to solve for the 
correlation diffusion equation. 
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1.6.2 DCS Models of Blood Flow ⟨r⟩ 
Since the orientations of the microvessels in the brain are fairly random, dynamic scattering 
associated with red blood cells is commonly modeled as pseudo-Brownian motion. In this 
model, the mean square displacement, <r()>, is equal to 6DB where DB is called the 
effective diffusion coefficient [28]. Using this definition, the solution to G1(ρ,𝜏) for a semi-
infinite homogeneous medium is given by:  
 
𝐺1 =⁡
3𝜇𝑠
′
4𝜋
[
exp⁡(−𝑘𝐷𝑟1)
𝑟1
−⁡
exp⁡(−𝑘𝐷𝑟2)
𝑟2
] 
1-27 
 
where, 𝑟1 ⁡= ⁡ [𝜌
2 ⁡+ ⁡𝑧0
2⁡]
1
2 and 𝑟2 =⁡ [𝜌
2 ⁡+⁡ (𝑧0 +⁡2𝑧𝑏)
2⁡]
1
2 . z0 is the effective depth of the 
source and is defined as 1/µ́s, zb is the extrapolated boundary and is defined as 
2D(1+Reff)∙(1−Reff)−1. D is the diffusion coefficient and Reff is the effective reflection 
coefficient given by 0.493 for the refraction indices of tissue and air [24][29]. It is common 
in DCS experiments to express the product αDB as a blood flow index (BFI), which has 
units of cm2/sec. 
1.6.3 DCS System 
The DCS system consists of a long coherence length laser that emits continuous near-
infrared light at a particular wavelength. The output from the source is fed to a multimode 
fiber to deliver the light to the tissue. A long coherence length laser ensures that the emitted 
light is in phase for distances that are much greater than the typical photon pathlengths 
within tissue. A single-mode or a few-mode fiber is used to collect the reflected light, which 
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is directed to a suitable detector. Fast photon counting avalanche photodiodes, most 
commonly a single photon avalanche photodiode (SPAD) are used. The detector’s output 
is fed into a correlator board that computes the normalized intensity autocorrelation 
function.  
The most commonly used correlator board works on a multi-tau scheme, which was first 
introduced by Schatzel in 1985 [30]. Multi-tau schemes were developed to decrease 
computational load. The board takes the TTL signal to generate an autocorrelation function 
using a large range of delay times, ranging from 10ns up to hours. The correlator consists 
of registers (typically starting at 32 registers) with different bin width (T0), which double 
after every few registers. When acquisition is initiated, a digital counter passes the photon 
counts as TTL pulses which are collected in time bins of the first register. This value is 
shifted to the right as each new value is updated from the left of the register. Each register 
is updated based on their T0 value. Since T0 doubles every few registers, the updating time 
for each register also varies with respect to T0. The temporal intensity autocorrelation 
function is calculated before each shift and the autocorrelation function is continuously 
averaged over the entire acquisition time t, whereas the delay time is the summation of all 
the bin widths on the left of the register. Using this technique, the computational load is 
greatly reduced as compared to the linear autocorrelator, but they do have limitations. For 
DCS applications, the lack of flexibility to compute over selected delay times makes 
hardware multi-tau correlators suboptimal since recorded correlation times are much 
smaller than the fixed ranged on the correlator board [31]. 
Recently, the development of software-based correlators has been proposed in order to 
provide a means of controlling the correlation times for DCS [32]. The approach feeds the 
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output of a SPAD into a high-speed counting board (PCIe-6612 National Instruments), 
which in turn is read by a high-level software program (LabVIEW) to compute 
autocorrelation functions with sub-second resolution. The advantage of this approach 
compared to a commercial hardware correlator, which measures correlation times over a 
wide and fixed range (1µs-1s), is the ability to measure only those correlation times 
relevant to blood flow (typically between 10 and 100 µs). Targeting the optimal range 
greatly enhances the signal-to-noise ratio, thereby allowing measurements with 
millisecond resolution [32]. 
1.7 Study Rationale 
DCS is an emerging noninvasive optical technique for monitoring relative CBF, but it does 
not provide a measure of absolute blood flow, making it difficult to assess if CBF drops to 
ischemic levels. To convert the DCS signal into units of CBF, it has been combined with 
DCE NIRS to estimate absolute flow. That is, a single value of CBF obtained using an 
optical contrast agent can be used to calibrate the BFI data obtained by DCS [23]. This 
approach requires combining two optical systems: NIRS for measuring CBF, and DCS for 
monitoring BFI, which adds to the complexity and cost of the system.  Therefore, it would 
be advantageous to develop a stand-alone DCS system capable of monitoring absolute 
CBF. This device could be used to establish ischemic threshold in preterm infants as 
currently there is no means of determining the magnitude of CBF fluctuations in preterm 
infants with impaired CA. 
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1.8 Research Objective 
The goal of my research work was to develop a portable system using DCS suitable for 
continuous monitoring and quantification of cerebral blood flow in preterm infants. To 
achieve this goal, the following objective were addressed: 
1.  Develop a stand-alone DCS system that incorporates a software correlator 
coupled to a multi-channel detection system in order to capture intensity and 
correlation data at multiple source-detector distance.  
2. Validate the ability of the multi-distance (MD) DCS system to measure tissue 
optical properties in a neonatal animal model (piglets). Validation was performed 
by independently measuring the optical properties using TR-NIRS. 
3.  Demonstrate the ability of the system to track changes in CBF caused by altering 
arterial carbon dioxide pressure (i.e. both low (hypocapnia) and high 
(hypercapnia) conditions). 
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Chapter 2  
2 Methods 
The motivation for monitoring cerebral hemodynamics in the NICU was provided in 
Chapter 1. Ideally, the device should be portable and compact for bedside monitoring and 
provide a means of assessing CBF considering the link between blood flow instabilities 
and neonatal brain injury. This chapter outlines the development of a multi-distance DCS 
system designed for this purpose. The key modification to the system was the replacement 
of a hardware correlator with an in-house-developed software version. This enabled the 
acquisition of multi-distance intensity measurements to measure the tissue optical 
properties based on spatially resolved NIRS methodology. In addition, CBF was measured 
by acquiring DCE absorption changes using indocyanine green (ICG) as an intravascular 
contrast agent. By measuring absolute CBF, the DCS blood flow index could be converted 
into units of blood flow, enabling DCS to monitor CBF without requiring a separate NIRS 
system for the DCE experiments. 
The experiments outlined in this chapter were conducted to test the sensitivity of the multi-
distance DCS system to changes in CBF. Experiments were conducted in newborn piglets 
as the thickness of the extracerebral tissues (scalp and skull) is negligible, similar to 
preterm newborns. CBF was altered by manipulating arterial carbon dioxide tension 
(paCO2): elevated paCO2 (i.e., hypercapnia) to increase CBF and reduced paCO2 (i.e., 
hypocapnia) to decrease CBF. In addition, the optical properties were measured 
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independently by TR-NIRS for comparison to measurements obtained by MD-DCS 
system.  
2.1 Animal Preparation 
Animal experiments were conducted in accordance with the guidelines of the Canadian 
Council of Animal Care (CCAC) and approved by the Animal Care Committee at Western 
University. Newborn piglets (<10 days old, 3.02±1.37 kg, 4 females, 3 males) were initially 
anesthetized with 5% isoflurane, which was reduced to 3% for surgical procedures and 
maintained at 2-2.5% during the course of the experiment. Animals were tracheotomized 
and mechanically ventilated on a mixture of 2 L oxygen and 2 L medical air (21% O2, 
balance N2). Vital signs including heart rate (HR), end-tidal carbon dioxide tension, 
respiratory rate (RR), and blood pressure were continuously monitored (SurgiVet, Smith 
Medical, MN) via a femoral artery catheter. Arterial oxygen saturation was measured by a 
pulse oximeter attached to the piglet’s right front hoof. Intermittent arterial blood samples 
were collected via the femoral catheter for blood gas and glucose analysis (Radiometer, 
ABL 80 FLEX CO-OX, Denmark). An ear and cephalic vein were catheterized for IV 
access, which included injecting ICG injections (Sigma-Aldrich, Saint Louis, MO) and 
infusing NaCl fluids (4 ml/kg/h). The piglet’s scalp was shaved and the piglet was placed 
in a prone position within a plexiglass jig to help support a custom-made optical fiber probe 
holder, which held the DCS and TR-NIRS probes to the scalp throughout the experiment. 
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2.2 Experimental Procedure 
The DCS optical fibers were positioned on the head at source-detector separations of 15, 
20 and 25 mm. TR-NIRS optical fibers were placed parallel to the DCS holder, ensuring 
that they interrogated the same brain region, at a source-detector distance of 30 mm. 
Measurements from the two systems were acquired sequentially, with shutters placed in 
front of the TR-NIRS and DCS lasers, as well as the TR-NIRS photomultiplier tube (PMT). 
This prevented cross-talk between the two systems when collecting sequential data.  
DCS and TR-NIRS data were acquired at each capnic level, starting with the baseline 
condition (normocapnia). At each level, TR-NIRS and MD-DCS data were collected to 
determine the tissue optical properties. In addition, DCE intensity data were collected with 
the DCS system in order to quantify CBF. The procedure involved a bolus injection of ICG 
(0.1 mg/kg in 1 ml of sterile water and dextrose used in equal ratio) into the ear vein, 
followed by acquiring a series of intensity measurements at a temporal resolution of 
300 ms. At the same time, the time-varying arterial concentration curve was measured by 
a pulse dye densitometer (DDG 2001, Nihon Kohden, Tokyo, JP) attached to the right 
forelimb.  
During the transition between capnic levels, DCS data were continuously recorded to track 
the dynamic changes in the BFI. Measurements were taken for 20 minutes, encompassing 
a 5 minute period prior to CO2 manipulation and 15 minutes following. The DCE protocol 
discussed above was performed at the end of each 20 minute period to measure CBF at the 
new paCO2 value. Following each measurement, the animal’s CO2 level was returned to 
baseline before transitioning to a new state. To achieve hypercapnia, the piglet was 
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ventilated with 5.25% of CO2 (0.5 L O2 and 3.5 L CO2) in order to accomplish a rapid 
change in capnic level, whereas hypocapnia was induced through hyperventilation to blow 
off CO2. All experiments started at baseline and the order of hyper and hypocapnia was 
randomized. 
2.3 Instrumentation 
2.3.1 Diffuse Correlation Spectroscopy 
The DCS system consisted of a long coherence length (>5 m) continuous-wave laser 
operating at 785 nm, with a maximum power output of 100 mW (DL-785-100-3S, 
CrystaLaser, Reno, NV). The laser was coupled to a multimode fiber (NA = 0.22, 
core = 400 µm, 4.7 mm outer diameter; Fiberoptics Technology, Connecticut, US) which 
directed the light to the head. The reflected light was collected by three 2.5 m long single-
mode fibers (SMF-28-J9, NA = 0.14, core = 8.2 µm, single-mode cutoff wavelength 
= 1260 nm, Thorlabs, New Jersey, US) placed at 15, 20, and 25 mm source-detector 
distance and mounted to the head using a custom-designed 3D-printed probe holder. Each 
detection fiber was wrapped into a 15 cm coil to attenuate higher order modes by 
converting them into non-propagating modes [33][23]. Light from the detectors was 
received by a multi-channel single photon counting APD (SPCM-AQR-15-FC, 
PerkinElmer Canada Inc, Quebec, CA), which fed TTL pulses into an edge-detecting 
counter on a PCIe6612 counter/timer data acquisition board (National Instrument, Austin, 
Texas). Photon counts were recorded and processed using in-house developed software 
(LabVIEW, National Instrument and MATLAB) to generate intensity autocorrelation 
curves (g2) (Fig 2.1). 
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The advantage of this approach compared to commercial hardware correlators, which 
measure correlation times over a wide and fixed range (1 µs – 1 s), is the ability to measure 
only those correlation times relevant to blood flow (typically between 10 and 100 µs). DCS 
measurements were conducted with a minimum baseline duration of 2 min at a temporal 
resolution of 300 ms; g2 curves were computed using 40 delay time points (i.e. from 1 to 
30 µs). 
 
The other advantage of developing a software correlator is that the photon count from each 
detector can be recorded. This, in addition to the baseline autocorrelation data, was used to 
measure the tissue optical properties as explained in the next section. Changes in the photon 
count were also recorded during the ICG bolus tracking measurements. In this case, the 
Figure 2-1: Software-based DCS system consisting of a 785 nm laser incident on the tissue 
surface and detectors placed 15, 20, and 25 mm from the source. Emitted light is scattered 
within the tissue and directed to APDs, which produced a train of TTL pulses that are fed 
into the counting board, which stores them in an internal buffer. The normalized 
autocorrelation curve is then computed. 
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temporal resolution was 300 ms and total acquisition time was 90 s. An intravenous bolus 
injection ICG was given at the 10 s mark. 
2.3.2 Time-Resolved NIRS 
The TR-NIRS system utilized a picosecond diode laser emitting at 802 nm (LDH-P-C-810, 
PicoQuant, Germany) (Figure 2-2). The output and pulse repetition rate of the laser were 
set to 1.4 mW and 80 MHz, respectively, through a computer-controlled laser driver (PDL 
828, PicoQuant). The light was coupled into a multimode fiber (NA = 0.22, core = 400 µm, 
4.7 mm outer diameter; Fiberoptics Technology, US) and directed towards the head. 
Reflected light was collected by a fiber bundle (core = 3600 µm, NA = 0.55, Fiberoptics 
Technology, United States) placed 30 mm from the emission fiber on the piglet’s head. 
The collected photons were then sent to a hybrid photomultiplier tube (PMA Hybrid 50, 
PicoQuant, Germany), coupled to a HydraHarp 400 (PicoQuant, Germany) time-correlated 
single photon counting module to record the arrival times of the photons. TPSFs were 
computed using LabVIEW software. To measure the tissue optical properties, a TPSF was 
acquired over a 60 s period. The temporal dispersion caused by the system was corrected 
for by measuring the IRF. To avoid artifacts, such as instrument temporal drift, the TR-
NIRS system was allowed 1 h to warm up prior to the experiment. 
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2.4 Data Analysis 
2.4.1 Measuring the Tissue Optical Properties by DCS and TR-
NIRS 
To measure the tissue optical properties using MD-DCS, the effective attenuation 
coefficient (µeff) was determined from the light intensity measurements acquired at the 
different source-detector distances using the principals of spatially resolved NIRS, where 
µeff is given by: 
 
𝜇𝑒𝑓𝑓 = √(3𝜇′𝑠(𝜆) ∙ 𝜇𝑎(𝜆)) 
2-1 
Figure 2-2: TR-NIRS system consisting of a 802 nm picosecond 
laser placed 30 mm away from the detector on the piglet head. 
Detected light from the PMTs is transferred to the computer for 
computation of TPSFs. 
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µeff is the slope of intensity versus distance plot, as given by: 
 ln[𝑟𝑠𝑑
2 ∙ 𝐼(𝑟)] = −𝜇𝑒𝑓𝑓 ∙ 𝑟𝑠𝑑 + 𝐼0(0) 2-2 
where, I(r) is the light intensity detected at a specific source-detector distance and I0 is the 
light intensity at rsd = 0. 
The next step was to fit the acquired normalized intensity autocorrelation (g2) curves, 
which were generated by the software correlator by: 
 
𝑔2(∆n = τfs) =
〈𝑛(𝑖)𝑛(𝑖 + ∆𝑛)〉
〈𝑛(𝑖)〉〈𝑛(𝑖)〉
 
2-3 
where n(i) was the photon count at a time interval at index i on the internal buffer, fs is the 
sampling frequency of the system operating at 1 MHz and ⟨⟩ represent the time averages 
over navg = ntotal−∆n points. The g2 curves were fit using the solution to the correlation 
diffusion equation for a semi-infinite homogeneous medium, assuming Brownian motion 
of scatterers (as discussed in section 1.6): 
 
𝐺1 =
3𝜇𝑠
ʹ
4𝜋
(
𝑒−𝑘𝐷𝑟1
𝑟1
−
𝑒−𝑘𝐷𝑟2
𝑟2
) 
2-4 
 
where kD
2= µeff
2 + 6µsʹk02αDB. The term DB is the blood flow index. The two fitting 
parameters were µs and DB with µeff set to the value from the spatially resolved analysis. 
The final step was to determine µa from Equation 2-1 using the estimates of µs and µeff. 
To determine the optical properties by TR-NIRS, the measured TPSFs were fit using the 
solution to the diffusion equation for semi-infinite homogeneous medium using 
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extrapolated boundary conditions[34]. The IRF of the apparatus was also measured and 
convolved with the analytical solution. A non-linear optimization routine was used to fit 
the model convolved with the IRF to each measured TPSF [35]. All analyses were 
conducted using the MATLAB function fminbound. 
2.4.2 DCE Measurements of Absolute CBF 
The procedure underlying the bolus tracking technique for quantifying the CBF is based 
on measuring the change in signal intensity caused by the passage of ICG through the 
microvasculature. This approach models the ICG passage as a linear time-invariant system. 
That is, the time-varying concentration of ICG in tissue, C(t), is linearly proportional to its 
concentration in arterial blood concentration, Ca(t), and CBF is assumed constant during 
the measurement period, which is typically ~ 60 s. Based on these assumptions, C(t) is 
related to Ca(t) by the convolution operator: 
 
𝐶(𝑡) = 𝐶𝐵𝐹 ∙ ∫ 𝐶𝑎(𝑡 − 𝑢). 𝑅(𝑢)𝑑𝑢
𝑡
0
 
2-5 
where R(t) is the impulse residue function, which represents the fraction of ICG in tissue 
at time t following an ideal unit impulse injection at time t = 0. C(t) was determined from 
intensity change due to the passage of ICG through the cerebral microvasculature as 
recorded by the multi-distance DCS system, and Ca(t) was measured by the DDG (dye 
densitogram) as outlined in Section 2.2. The flow-scaled impulse residue function, 
CBF∙R(t), was extracted from Ca(t) and C(t) by performing a deconvolution and its initial 
height is equivalent to CBF, since by definition R(0) = 1 [36]. 
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C(t) was determined using the solution to the diffusion approximation for a semi-infinite 
medium to extract the time-varying change in absorption, µa(t), from the intensity 
measurements at the largest source-detector distance: 
 
𝐶(𝑡) =
[(𝜇𝑎(𝑡) − 𝜇𝑎(0))]
[ln(10) × 𝜀𝐼𝐶𝐺]
 
2-6 
where µa(0) represents the baseline absorption coefficient and εICG is the extinction 
coefficient of ICG at 785 nm. The analysis required using the measured baseline optical 
properties, µa and µs, as input parameters. For comparison, it was performed separately 
using the estimated of µa and µs, from MD-DCS and from TR-NIRS. Changes in light 
absorption due to ICG were characterized using µa as a fitting parameter, while keeping 
µsfixed to the baseline value. 
2.4.3 Dynamic CBF 
To determine the change in CBF from baseline to either hyper or hypocapnia, each g2 curve 
in the time series between levels was fit to extract the BFI (i.e., DB) as a function of time. 
The value of CBF measured by the DCE method was used to convert the BFI time series 
into units of CBF (ml/100g/min): 
 
𝐶𝐵𝐹(𝑡) =
𝐵𝐹𝐼(𝑡)
𝐵𝐹𝐼0
× 𝐶𝐵𝐹0 
2-7 
 
where BFI(t) is the flow index at time t, BFI0 is the baseline value, and CBF0 is the value 
of blood flow determined by the DCE method. 
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2.5 Statistical Analysis 
Statistical analyses were conducted using SPSS 17.0 (SPSS, Chicago, USA) and statistical 
significance was described as p < 0.05. Linear regression analyses were conducted to 
investigate the correlation between estimate of optical properties from TR-NIRS and MD 
DCS as well as the CBF values derived from the two sets of optical properties. An analysis 
of variance (ANOVA) was also used to determine the difference in optical properties 
between techniques and conditions. Finally, the degree of similarity between CBF 
measurements acquired by the two techniques was evaluated using a Bland-Altman plot 
[37] 
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Chapter 3  
3 Results 
3.1 Physiological Parameters 
A total of 8 piglets were studied; however, one set was excluded due to poor quality of the 
baseline autocorrelation curves, resulting in no convergence in the fitting. The poor quality 
of this data set was attributed to poor contact of the probes on the piglet’s scalp. Average 
values of the physiological parameters measured at each capnic condition from the seven 
successful experiments (4 females, 3 males, mean weight = 3.02 ± 1.37 kg, mean age 
= 6.7 ± 2.9 days) are summarized in Table 3-1. 
 
Condition paCO2 
(mmHg) 
paO2 
(mmHg) 
ctHb 
(g/dL) 
HR 
(bpm) 
MAP 
(mmHg) 
pH 
Baseline 39±2 230±76 7.1±1.2 157±16 47±2 7.39±0.02 
Hypercapnia 63±5* 120±26* 7.4±1.13 189±31* 49±4 7.24±0.03* 
Hypocapnia 28±2* 284±74* 7.3±1.5 168±15* 46±3 7.52±0.02* 
Table 3-1: Average physiological parameters ± standard deviation at baseline, hypercapnia 
and hypocapnia. * indicates significant difference relative to the baseline value. 
(pH = arterial pH; paCO2 = partial pressure of carbon dioxide in arterial blood; paO2 = partial pressure of 
oxygen in arterial blood; ctHb = hemoglobin concentration; HR = heart rate; MAP = mean arterial pressure) 
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Of all the measured parameters, significant differences were observed in paCO2, paO2, HR 
and pH under both conditions relative to baseline, whereas no significant difference in 
MAP or ctHb was noted under both conditions. 
3.2 Optical Properties 
Mean optical properties measured by MD-DCS and TR-NIRS are shown in Table 3-2. The 
scattering coefficient was calculated at baseline only, whereas the absorption coefficient 
was computed at baseline, hypercapnia and hypocapnia.  
Technique 
µsʹ (cm-1) µa (cm-1) 
Baseline Baseline Hypercapnia Hypocapnia 
TR-NIRS 7.51±1.59 0.11±0.02 0.13±0.02 0.12±0.01 
MD-DCS 7.0±1.58 0.08±0.03 0.09±0.03 0.07±0.02 
Table 3-2: Optical properties ± standard deviation calculated by TR-NIRS and MD-DCS 
of 7 animals at 802 nm and 785 nm. Values are presented at baseline for µsʹ and at baseline, 
hypercapnia and hypocapnia for µa.  
Figure 3.1 shows the regression plot of the baseline µs values measured by TR-NIRS and 
MD-DCS. The graph revealed a strong linear correlation (R2= 0.874) between the µsʹ values 
from the two techniques with a slope of 0.93 and an intercept of 0.056 cm-1. 
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The correlation between mean values of the absorption coefficient measured by TR-NIRS 
and MD-DCS at the three capnic conditions is shown in Figure 3-2. The results showed a 
good correlation between the techniques (R2 = 0.70, slope = 0.89 and a y-
intercept = 0.048 cm-1).  
  
Figure 3-1: Regression plot (filled circles) comparing µsʹ values measured by TR-
NIRS and MD-DCS. The solid line is the best-fit from linear regression (slope = 0.92, 
intercept = 0.056 cm-1 and R2 = 0.87). 
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The multi-variate ANOVA revealed two statistical effects on µa across conditions 
(baseline, hypercapnia and hypocapnia) and techniques (MD-DCS and TR-NIRS). That is, 
µa was significantly different across the three conditions (F2,12 = 35.25, p<0.05) and 
significantly different between techniques (F1,6 = 7.7, p<0.05). 
3.3 DCS and DCE Data Under Different Flow Conditions 
Measured normalized intensity autocorrelation functions and corresponding tissue ICG 
curves from one animal are shown in Figure 3.3. Data from each technique are shown under 
the three flow conditions: baseline, hypercapnia and hypocapnia. As expected, when CBF 
increased the autocorrelation curve decayed faster and visa-versa when blood flow 
Figure 3-2: Regression plot of µa measured by TR-NIRS and MD-DCS under the 3 
capnic levels. The dashed line is the best-fit from linear regression (slope = 0.89, intercept 
= 0.048 cm-1 and R2 = 0.70). Data are presented as the mean ± standard error. 
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decreased. A similar trend was observed with the ICG tissue concentration curves. That is, 
the peak and initial rise of the first pass time both increased as CBF increased going from 
hypocapnia to hypercapnia. 
 
3.4 CBF Measurements  
Mean CBF values obtained from the DCE data using baseline optical properties measured 
by TR-NIRS and MD-DCS are shown in Table 3-3 for the three capnic conditions. Figure 
3-4 shows the regression plot between the two sets of CBF values. A strong correlation 
was found with an R2 = 0.924, slope of 0.91 and y-intercept of 4.27 ml/100g/min. The 
results of a multi-variate ANOVA revealed significant differences in CBF across 
Figure 3-3: (A) Typical normalized intensity autocorrelation functions and (B) the 
corresponding tissue ICG curves measured at baseline, hypercapnia and hypocapnia 
in one animal. Each curve in (A) was obtained by averaging a set of curves over a 
2 minute acquisition period. 
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conditions (F2,12 = 14.314 and p<0.05), but no significant difference between CBF values 
obtained with the two sets of optical properties. 
Technique 
Condition 
Baseline Hypercapnia Hypocapnia 
CBFTR-NIRS 
(ml/100g/min) 
28.03±14.43 37.31±10.63 19.69±6.25 
CBFMD-DCS 
(ml/100g/min) 
26.34±14.70 35.54±12.32 17.44±6.58 
Table 3-3: CBF values (mean ± standard deviation) calculated for 7 animals 
under baseline, hypercapnia and hypocapnia from optical properties derived 
from TR-NIRS and MD-DCS.  
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Figure 3-5 shows the Bland-Altman plot comparing the two sets of CBF measurements. 
The mean difference between both the techniques was 1.9 ml/100g/min, which was bound 
by 95% confidence intervals of -5.77 and 9.58 ml/100g/min. 
Figure 3-4: Regression values comparing CBF values derived from DCE data using 
optical properties from TR-NIRS and MD-DCS 
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3.5 Flow Changes During Change in Capnic Level:  
Illustrative plots of the temporal change in absolute CBF during the transitions from 
baseline to hypercapnia and to hypocapnia are shown in Figure 3-6. These CBF time plots 
are from separate animals and in each case the relative change in the blood flow index was 
converted to units of absolute CBF using a single baseline DCE measurement. The changes 
in blood flow from baseline to hypercapnia were more rapid than the corresponding change 
from baseline to hypocapnia because of the difference in how each capnic condition was 
induced. That is, hypercapnia was achieved by incorporating a small fraction of CO2 into 
the breathing circuit, while hypocapnia was induced by hyperventilation. 
Figure 3-5: Bland-Altman plot comparing the CBF measurements obtained using 
baseline optical properties from TR-NIRS and MD-DCS. Mean difference between the 
two methods is indicated by the solid line and the 95% confidence interval is demarcated 
by the dashed line. 
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Figure 3-6: CBF time course during (A) a hypercapnia challenge and (B) a 
hypocapnic challenge of two animals. The vertical dotted line at 5 minutes 
indicates the end of baseline and start of the capnic challenge. 
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Chapter 4  
4 Discussion 
In this thesis, the development of a DCS system capable of measuring absolute CBF was 
presented. The key modification to an existing DCS system [24] was replacing a 
commercial hardware correlator with an in-house-developed software version that enabled 
the acquisition of light intensity and autocorrelation functions at multiple source-detector 
distances. The concept of using a software correlator for DCS was initially purposed to 
optimize the measured correlation times, thereby provided faster acquisition times 
[32],[38]. In this study, switching to a software correlator provided the ability to record 
light intensity, which was used to track the temporal changes in absorption caused by the 
passage of ICG through the cerebral vasculature. These changes were subsequently 
converted to a tissue ICG concentration curve using the baseline optical properties (a and 
µs) derived by a combination of spatially resolved light intensity measurements and 
normalized intensity autocorrelation functions. The data presented in Figure 3.3 
demonstrated that this approach could produce ICG concentration curves with high contrast 
to noise and was sensitive to blood flow changes. A previously validated deconvolution 
routine [23] was used to extract CBF from the recorded tissue and arterial ICG 
concentration curves. As a final step, the derived CBF value was used to convert relative 
blood flow data determined by DCS into units of absolute flow (e.g. Figure 3.6).  
The concept of combining bolus-tracking and DCS techniques was first proposed by Diop 
et al. [23]. Using the same animal model as in the current study (newborn piglets), a strong 
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linear correlation between CBF measured by DCE-NIRS and the BFI measured by DCS 
was reported (R2 = 0.93) over a flow range from 17 to 90 ml/100g/min. This study 
highlighted the value of combining a quantitative NIRS method – in this case TR-NIRS – 
with DCS, as NIRS could be used to obtain the tissue optical properties and conduct a DCE 
experiment to determine CBF. The limitation was the need to combine two optical 
methods, which increases costs and the overall complexity of the system [23]. The MD- 
DCS approach developed in this thesis offers a less expensive and simpler alternative for 
monitoring CBF. Furthermore, it avoids any potential partial volume errors between 
optodes from separate systems and ensures the optical properties are measured at the same 
wavelength as the DCS data are acquired. 
The first study to propose using MD-DCS to measure BFi, µsʹ and µa was by Farzam et al. 
The idea was MD measurements would provide sufficient additional information to extract 
all three parameters. However, the signal-to-noise required to avoid crosstalk between the 
three fitting parameters limited the techniques to small source-detector separations (<2 cm) 
[39]. Recently, Tamborini et al. expanded this idea by acquired DCS data at both multiple 
wavelengths and source-detector separations to measure blood oxygenation and BFI. 
Estimates of five fitting parameters (BFI, two scattering terms, and concentrations of HbO 
and Hb) were obtained from a single cost function that included measurements of 
correlations times and light intensity at four source-detector distances and two 
wavelengths. Experiments involving tissue mimicking phantoms were used to demonstrate 
the importance of using both multi-distance and multi-wavelength measurements to 
accurately measure all fitting parameters, particularly s´ [40].  
44 
 
The current study followed a similar approach to Tamborini et al. by collecting intensity 
and correlation measurements at multiple source-detector distances. However, the focus 
was solely on measuring the baseline optical properties to derive tissue ICG concentration 
curves and not on estimating tissue oxygenation. Consequently, data were only recorded at 
a single wavelength, reducing the number of unknowns to BFI, a and s´. In addition, the 
two studies differed in how the MD intensity and correlation measurements were 
combined. In the current study, a three-step procedure was implemented: First,eff was 
extracted from the MD intensity measurements, analogous to spatially resolved NIRS. 
Next, the intensity autocorrelation curves obtained at multiple source-detector distances 
were fit with the diffusion approximation (Equation 1.24), which involved only two 
parameters (s´ and BFI) since eff was determined in the first step. Finally, a was 
estimated using Equation 2.1. The strong correlation between s´ estimates obtained by 
MD-DCS and TR-NIRS (figure 3.1) demonstrated that the former can measure s´, despite 
the prediction by Tamborini et al. that data from multiple wavelengths are required. This 
is likely due to the difference in the number of fitting parameters used in the two 
approaches.  
A correlation between a estimates from MD-DCS and TR-NIRS (Figure 3.2) was also 
found; however, the a values from MD-DCS were significantly lower than the 
corresponding TR-NIRS estimates, and the between-subject variation was approximately 
70% greater for MD-DCS (Table 3.2). The most likely cause was errors in eff considering 
the good agreement between s´ estimates from the two techniques. The primary 
assumptions of spatially resolved NIRS are that the tissue can be modelled as a semi-
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infinite medium and the reflectance measurements are acquired on a flat surface. It is 
known that extracerebral tissues (scalp and skull) as well as cerebrospinal fluid in the 
subarachnoid space can affect the accuracy of spatially resolved measurements; however, 
the impact with respect to measurements on the piglet head should be minimal considering 
the depth to the brain from the skin surface is less than 3 mm [41]. The assumption of 
planer geometry can be violated if there is noticeable curvature to the head [42]. In the 
piglet experiments, the probes were positioned anteroposterior on one side of the head to 
achieve as closely as possible the required probe geometry. However, the dimensions of 
the piglet’s cranium are relatively small and, therefore, some deviation was possible.   
Despite the discrepancy in a values between the two NIRS techniques, the CBF estimates 
obtained by analyzing the DCE data using the two sets of optical properties (Figure 3-4) 
were strongly correlated (R2 = 0.92) and the mean bias from the Bland-Altman analysis 
was small (1.9 ml/100g/min). Furthermore, the variability between animals under each 
capnic condition was similar for the two sets of optical properties (Table 3-3). The CBF 
estimates did not show the variability observed with a because the diffusion equation 
(Equation.1-16) used to obtain tissue ICG concentration curves is primarily dependent on 
s´ and eff, and the latter is proportional to the square root of a. These results indicate that 
the accuracy of the optical properties obtained from MD-DCS was sufficient for estimating 
CBF and a separate NIRS system specifically for measuring baseline a and s´ is not 
necessary. 
A potential complication with combining DCS with a bolus-tracking method is the effects 
of ICG on μa, which can affect BFI measurements. To minimize this effect, each ICG 
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injection was followed by a 15-min delay to allow sufficient time for the dye to clear from 
the circulation. Previous experiments showed that the change in µa after the first pass of 
ICG is typically around 5%, which would translate into a 2% error in BFI [23].  
There are a number of potential limitations with this study. First, the optical properties 
measured by the two techniques were not at the same wavelength: TR-NIRS acquired data 
at 802 nm while and DCS measurements were at 785 nm. A previous study reported that 
this wavelength difference would lead to differences in optical properties of the order of 
5% [23]. Second, TR-NIRS was only used to measure µa and µsʹ, and not to acquire a 
separate set of ICG concentration curves. The latter was not performed because the most 
direct means of measuring the absorption effects caused by the passage of ICG is by 
measuring the changes in light intensity. In contrast, TR-NIRS requires careful attention to 
ensure a linear relationship between dynamic absorption changes and the recorded 
distributions of times of flight [23]. 
Another potential limitation with the study was that hypercapnia was induced by adding 
6% CO2 to the inhaled gas mixture rather than altering the animal’s breathing rate and 
volume, such as performed to induced hypocapnia. The former was conducted in order to 
elicit a rapid increase in paCO2, which in turn would lead to a rapid CBF response. 
However, introducing the CO2 tank into the breathing circuit required reducing the O2 flow, 
which resulted in a significant drop in paO2 relative to baseline (Table 3-1). Despite this 
decrease, paO2 remained within normal limits and its effects on CBF would be small 
relatively to the large increase in paCO2.   
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Chapter 5  
5 Conclusions and Future Work 
Based on the objective of developing a stand-alone DCE system capable of monitoring 
absolute CBF, I have: 
1. Developed software to record intensity data and generate autocorrelation functions. 
2. Modified a DCS system to record data at multiple distances using a multi-channel 
counter system. 
3. Demonstrated the ability of the MD-DCS system to measure tissue optical 
properties, which were validated against TR-NIRS. 
4. Presented experimental data results showing how the developed system can 
quantify CBF using a bolus tracking technique and can track changes in CBF.  
Based on these results, a potential next step would be to conduct a clinical study to 
determine blood flow thresholds that are related to brain injury in preterm infants under 
intensive care. This would be analogous to studies of ischemic stroke in the mature brain 
that have shown that the extent of brain injury is related to both the drop in CBF and the 
duration of ischemia. Regarding neonatal brain injury, the goal would be to determine if 
there are flow thresholds in terms of the magnitude of the decrease in CBF and its duration 
that can be related to risk of brain injury (either IVH or PVL) developing. It is important 
to realize that normal CBF is considerably lower in the preterm brain relative to the mature 
brain and consequently specifically ischemic thresholds remain unknown in this 
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population. Hopefully, the MD-DCS approach developed in this work could help 
established critical ischemic thresholds. 
An additional application of the MD-DCS system would be to use the improved temporal 
resolution provided by the software-correlator to capture flow pulsatility. Analogous to 
approaches based on transcranial Doppler, DCS measurements of flow pulsatility can be 
used to assess the critical closing pressure, which is the value of the arterial blood pressure 
at which CBF approaches zero [43] The procedure does require blood pressure monitoring, 
which is performed in the neonatal intensive care unit. Investigating critical closing 
pressure in preterm infants has not seen a lot of attention, likely due in part to the lack of a 
suitable neuromonitoring technique.  
The developed MD-DCS system used a single wavelength to measure the optical properties 
and CBF. Recent studies have shown that total hemoglobin concentration and oxygen 
saturation can be extracted by collecting DCS data at multiple wavelengths [40]. However, 
this requires developing a suitable laser drive to cycle between the two lasers that must 
provide suitable coherence to perform correlation analysis. 
Finally, the present system targets neonates, who have negligible extracerebral signal 
contamination. Adapting this technology to adults would be challenging due to presence 
of extracerebral tissues that are of the order of 1 to 1.5 cm thick. The spatially resolved 
approach used to compute µeff is invalid for the adult head and therefore, translating this 
technology to adults would require an alternative approach. Recently, the concept of TR-
DCS was proposed to combine DCS with the improved depth sensitivity of TR detection 
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[44]. However, the required technology is currently complex and requires more 
development. 
In summary, the ability to continuously measure absolute flow could help improve the 
outcome of patients at risk of brain injury by early identification of abnormal CBF. 
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Appendix A 
The software correlator used in this thesis was adapted from the work presented by Wang 
et al [32]. It was implemented on a standard personal computer using a PCIe 6612 
counter/timer data acquisition board (National instruments, Texas, US) and a customized 
software program (LabVIEW, National Instruments, Texas, US). As shown in the 
schematic below, the digital pulses from each of the three channels generated by the photon 
counting APDs were transferred to three of the 8 edge-detecting photon counters on the 
PCIe board. The counters were synchronized by an internal timebase of 80 MHz, which 
updated its internal count by one when a TTL pulse was detected. These counts were then 
transferred to the internal buffer at a pre-defined sampling frequency of 1 MHz, which 
defines the bin width of the internal buffer (fs=1/Δt). The counts were stored in the buffer 
(N(i)) at a pre-set temporal resolution of 300 ms given by tint. The number of points on the 
buffer (nint = fs × tint) were transferred to the computer for storage, which were subsequently 
used to compute the autocorrelation function at each source-detector distance using 
Equation 2-3. The LabVIEW software computed the normalized intensity autocorrelation 
in real time using a buffered producer-consumer loop over 40 delay times that ranged from 
1 to 30 µs.  
 
Figure L-1: Schematic of the software correlator operation 
showing the counter operation in the PCIe-6612 data 
acquisition board. (Adapted from Wang et al. 2016) 
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